L-094-2020
Agreement ID
L-094-2020
Lead IC
NCI
Exclusivity
Nonexclusive
External Party
Innovative Cellular Therapeutics
Fiscal Year
2020
Territory
Worldwide
Execution Date
Effective Date
Export Date